Drugmakers ‘premature’ in requests for metal impurity data
April 5, 2012Manufacturing and Production ICH, manufacturing, metal impurity
Pharmaceutical manufacturers are acting ‘prematurely’ when asking excipient suppliers to provide metal impurity levels, according to a new position paper …
Lonza names Ridinger as new chief executive
April 5, 2012Manufacturing and Production Cognis, Lonza, Ridinger
Swiss contract manufacturer and ingredients supplier Lonza has appointed Richard Ridinger as its new chief executive, replacing Stefan Borgas who …
AstraZeneca signs respiratory pact with Amgen
April 5, 2012Research and Development Amgen, AstraZeneca, MedImmune, respiratory
AstraZeneca has bought its way into Amgen’s inflammation portfolio with a $50 million upfront payment to co-develop and commercialise five …
Orphan Medicinal Products in the EU- Free Webinar
April 4, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Orphan Medicinal Products in the EU: Eligibility, Orphan Designation and IncentivesThe structure of this webinar is:Introduction: Legislative Basis and Criteria …
NHS spending on drugs fell in 2011
April 4, 2012Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend
The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …
GSK’s diabetes drug misses goal
April 4, 2012Research and Development, Sales and Marketing Bydureon, GSK, Victoza, albiglutide, diabetes
GlaxoSmithKline has insisted its new long-acting Type 2 diabetes drug albiglutide remains on course for filing following topline results from …
EMG appoints two new senior members
April 4, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing EMG, Matthew Speers, Steve Turley, UCB
A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG). EMG is the voice of …
Glyn Edwards appointed as chief executive of Summit
April 4, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Glyn Edwards, summit
Summit, a UK drug discovery company, has appointed Glyn Edwards as its new chief executive. Edwards will take up the …
EMA creates new conflict of interest rules
April 4, 2012Sales and Marketing EMA, Lonngren, conflict of interest
The European Medicines Agency has introduced new rules to tighten up conflicts of interest, and have less reliance on pharma …
New Europe-wide approach for the classification of commercially confidential information and personal data in MAAs
April 3, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The Heads of Medicines Agencies(HMA) and the European Medicines Agency (EMA) have adopted a joint guidance document, providing a consistent …
Catalent Extends Development and Analytical Solutions Capabilities in Swindon, UK
April 3, 2012Research and Development
Somerset, NJ – March 22, 2012 — Catalent Pharma Solutions today announces the completion of new Development and Analytical Solutions’ …
Bayer cancer drug meets Phase III goal
April 3, 2012Research and Development, Sales and Marketing Bayer, Cancer, Glivec, Novartis, phase III, regorafenib
Bayer’s stomach cancer pill regorafenib has significantly improved progression free survival in late-stage patients. Results from the Phase III trial …
Life appoints new digital developer
April 3, 2012Business Services, Medical Communications, Sales and Marketing Life, Nick Douglas
Life Healthcare Communications has created a new digital developer role, continuing the growth of its digital department. The firm has …
Standardised equipment and centralised spirometry for optimal data quality
April 3, 2012Research and Development
IntroductionWhen developing the treatments for asthma and COPD, pharmaceutical companies utilise pulmonary function testing (PFT) to determine each compound’s efficacy. …
Considerations with dual site production
April 3, 2012Research and Development
There are generally two options available when looking to expand storage capacity – build to develop existing facilities or select …
Novasep expands in China, raises €40m for investments
April 3, 2012Manufacturing and Production China, Novasep, Shanghai, manufacturing
French processing equipment supplier Novasep has opened a new facility in China to meet what it says is increasing demand …
Pharma manufacturing news in brief
April 3, 2012Manufacturing and Production Gerresheimer and Foster Wheeler, Pharmax, Sigma-Aldrich
Pharmax starts building Dubai plant, Brazil tightens gelatin controls, plus updates from Sigma-Aldrich, Gerresheimer and Foster Wheeler.
Michael Cola resigns from Shire
April 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Cola, Shire
Michael Cola has resigned as the president of Shire Specialty Pharmaceuticals after seven years at the firm. “On behalf of …
NICE rejects Halaven for breast cancer
April 3, 2012Sales and Marketing Eisai, Halaven, NICE, breast cancer
NICE has rejected Eisai’s novel breast cancer drug Halaven, due to concerns over its safety and costs. In its final …
Moving Towards a Risk-Based approach to Clinical Trial Management
April 3, 2012Research and Development
Clinical trials need to be managed to rigorous standards in order to secure the quality and integrity of every aspect …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
